Year-end report 2021
Gothenburg, February 25, 2022 - Vicore Pharma Holding AB (publ) publishes the year-end report for 2021.Important events during the fourth quarter · In October, Vicore announced that the results from the phase 2 trial in COVID-19 (ATTRACT) were published in EClinicalMedicine, a scientific journal published by the Lancet. · In November, Vicore announced results from the ATTRACT phase 2 extension trial showing that C21 reduced long-term lung injury after COVID-19. Important events after the period · In February, an interim analysis of the AIR phase 2 trial in idiopathic